Lamyra
↗London, United Kingdom
Lamyra is a pharmaceutical company engaged in the development, manufacturing, and commercialization of a wide range of medical products, biologically active supplements, and cosmetic products. The company focuses on health maintenance, disease prevention, and longevity, with a portfolio that includes products for cold & flu, dermatology, gynecology, pediatrics, and gastroenterology.
The company operates internationally with a global footprint, maintaining research centers in the UAE, Belarus, Jordan, and Algeria. Its manufacturing sites are strategically located across Great Britain, the UAE, Poland, and Belarus, ensuring compliance with modern pharmaceutical industry standards.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Pharmaceuticals and Supplements
SIZE & FINANCIALS
Employees:51-200
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Lamyra-Pharmacare LLC
Key Partnerships:Quest Vitamins Middle East FZE (Manufacturing partner)
COMPETITION
Position:Niche Player
LINKS
Website:lamyra.org
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Lamyra and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Lamyra. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.